February 3, 2020 – Batavia, New York – First Wave Technologies, Inc. (“First Wave” and “company”), announces that the company’s Chief Executive Officer, Brian Bell, will be participating as a Discovery  Company in the 22nd Annual BIO CEO & Investor Conference in New York City.

22nd Annual BIO CEO & Investor Conference

Where: New York Marriott Marquis -1535 Broadway New York, New York 10036
When: Monday, February 10 –
Tuesday, February 11, 2020
Conf. Web Site: 2020 BIO CEO and Investor Conference

First Wave will be outlining near-term activities anticipated in 1H-2020 as well as providing updates on recent corporate developments as well as the company’s lead products: the CLARITY-IA® anesthesia system (FDA 510k regulatory clearance in process) and FIRST CRUSH® automated pill crusher.

To schedule a meeting, please use the BIO One-on-One Partnering™ portal for registered participants. Management is also available for 1:1 meetings outside the conference.  For further details, please contact: Jennifer K. Zimmons, Ph.D., Investor Relations, jzimmons@zimmonsic.com or +1.917.214.3514.

About BIO and the BIO CEO & Investor Conference

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. 

The 22st Annual BIO CEO & Investor Conference is one of the largest investor conferences that assemble a select group of established biotech companies, as well as top public and private equity investors and members of the sell-side investment community, to explore the current investment landscape and opportunities in life sciences. In addition to plenary sessions and panel discussions on timely business topics and key therapeutic areas, the conference features presentations and one-on-one meetings with over 150 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations.

About First Wave Technologies

First Wave Technologies, Inc. is a medical device company developing products for the acute care and long-term care market. The focus is to disrupt areas of healthcare with innovative products which have not seen meaningful change historically for the improvement of patient care. Current products are centered around improving the ease and accuracy of pharmaceutical delivery.  For more information, please visit http://www.firstwavetechnologies.com/ and http://firstwaveproducts.com/.

Corporate Contact:
Brian Bell
Chief Executive Officer and Director
First Wave Technologies, Inc.
99 MedTech Dr.
Batavia, New York 14020
Phone: +1 877.784.0269
E-mail: info@firstwavetechnologies.com

Investor Contact:
Jennifer K. Zimmons, Ph.D.
Investor Relations
Zimmons International Communications
Phone: +1.917.214.3514
Email: jzimmons@zimmonsic.com

# # #